Document is current

Article History

Received: 31 August 2025

Revised: 29 December 2025

Accepted: 19 January 2026

First Online: 5 February 2026

Declarations

:

: This study was supported by a research grant from GT Metabolic Solutions, Inc. (San Jose, CA), a company invested in magnetic surgery. GT principals were not involved in the research, writing, or editing of the manuscript. JP is a consultant for GT Metabolic Solutions, ReShape Lifesciences, Allurion, Medtronic, and Applied Medical; has received speaker honoraria from W. L. Gore, Olympus, Medtronic, Ethicon, and Intuitive; and holds indirect ownership interest through a family-held entity holding shares in GT Metabolic Solutions. RL is a consultant for GT Metabolic Solutions, Medtronic, and Gore; has received speaker honoraria from Medtronic, Ethicon, and Gore; holds indirect financial ownership in GT Metabolic Solutions through the Chicago Institute of Advanced Surgery; has educational fellowship grant from Gore; and is a Medical Director of General and Bariatric Surgery for Carrum Health. JB is a GT consultant with stock options who has received recent grants from Ethicon, Inc. (US), the Living Heart Foundation (US), and Clinique de la Sauvegarde, France. RP is a speaker and proctor for Teleflex/Standard Bariatrics, and a speaker for Intuitive and Medtronic.